TAPROS Mini ophthalmic solution 0.0015% for glaucoma or ocular hypertension (tafluprost)
What is TAPROS Mini ophthalmic solution 0.0015% for glaucoma or ocular hypertension (tafluprost)?
TAPROS Mini Ophthalmic Solution 0.0015% presents a highly efficient remedy for individuals contending with glaucoma and ocular hypertension. At its core lies the active component, tafluprost, which serves as a prodrug of tafluprost acid. Tafluprost acid, akin in structure and function to prostaglandin F2α, acts as a selective agonist at the prostaglandin F receptor, promoting increased outflow of aqueous fluid from the eyes. This effectively diminishes intraocular pressure, a characteristic feature of both glaucoma and ocular hypertension.
Beyond its mechanism of action, TAPROS Mini eye drops offer further benefits. Through consistent application, patients witness a notable decrease in intraocular pressure, thus reducing the risk of optic nerve damage and vision loss associated with these conditions. Consequently, TAPROS Mini becomes an indispensable component of treatment plans for glaucoma and ocular hypertension, providing patients with a dependable means to manage their conditions effectively.
Furthermore, the effectiveness of TAPROS Mini's active ingredients is supported by extensive research and clinical validation. Studies, such as "Tafluprost for the Reduction of Intraocular Pressure in Open Angle Glaucoma and Ocular Hypertension," consistently demonstrate tafluprost's superiority in affinity for the prostanoid FP receptor compared to alternative prostaglandins. This body of evidence solidifies its status as a leading option in strategies for treating glaucoma and ocular hypertension.
In addition to its therapeutic efficacy, TAPROS Mini offers practical advantages that enhance patient experience and adherence. Packaged conveniently in single-use bottles, it alleviates concerns regarding storage conditions and potential contamination. This not only ensures the medication's potency but also guarantees the safety of its administration—a vital consideration for individuals managing chronic eye conditions.
Active principles: tafluprost
Amount: 30 bottles * 0.3 ml
Indications: treatment of glaucoma and ocular hypertension
How to take: Apply 1 drop at a time, once a day.
Contraindications and precautions: After using the dropper, ensure its disposal. Once the tab is taken off, do not keep the leftover solution for future use. Patients with contact lenses must take off the lenses before applying and wait at least 5-10 minutes after applying before wearing the lenses again. Never apply while wearing contact lenses. This medication may temporarily induce blurred vision upon application. Avoid operating machinery or driving a vehicle until these symptoms subside. Do not expose to sunlight or heat. If any unusual symptoms like iris color change symptoms occur, discontinue use and consult with your doctor. Do not use in the following cases:
- pregnancy or breastfeeding,
- aphakic or pseudophakic eyes,
- bronchial asthma or a history of it,
- intraocular inflammation (iritis, uveitis).